Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000120

President and CEO acquired 27,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Brunn Carsten President and CEO 2021-09-24 Grant or award +27,200 256,572 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Brunn Carsten President and CEO 2021-09-24 Grant or award · Employee Stock Option (right to buy) +163,000 163,000 D: show line 2 in the form
Loading xslF345X03/wf-form4_163286110389016.xml…